ArticleFrontiers in pharmacology2024

Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator.

Jade Gauvin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.